Delivery Order SPE2DB22D1202-SPE2DB25FVFC8
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $7,642.65 to AmerisourceBergen Drug Corp for Provocholine Inhalation Solution in an 18ml pack configuration. The contract, issued on August 1, 2025, with an ultimate completion date of August 4, 2025, represents a firm fixed-price delivery order with no set-aside designation. Performance will be executed from the contractor's Conshohocken, Pennsylvania location. This delivery order is issued under AmerisourceBergen Drug Corp's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Provocholine Inhalation Solution in 18ML packs, with a contract ceiling value of $11,511.90. This firm fixed-price delivery order, which is not set-aside, represents a single transaction under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The product will...
- The Defense Logistics Agency awarded a $1,655.58 firm fixed price delivery order to AmerisourceBergen Drug Corp for Provocholine inhalation solution in 18ml packaging under contract 4569133382. The award, issued on August 18, 2025, with completion targeted for August 19, 2025, represents a child order under AmerisourceBergen's larger pharmaceutical supply vehicle. The contract is unset-aside and competitively awarded, with performance to occur at the company's corporate office location in...
- This is a firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution and healthcare solutions provider. The contract, valued at $7,077.65, is for the supply of Provocholine inhalation solution. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which supports the provision of a wide range of pharmaceutical...
- This delivery order, awarded on July 23, 2025, procures Provocholine inhalation solution in 18ML pack quantities for the Defense Department's Medical Supply Chain with a ceiling value of $6,732.76. The award is issued under firm fixed pricing with an ultimate completion date of July 24, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was selected as the awardee through competitive procurement with no set-aside designation. This delivery order is issued as a...
- This federal contract award is a delivery order valued at $4,265.39 issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider based in Conshohocken, Pennsylvania. The contract is for the provision of Provocholine Inhalation Solution, a pharmaceutical product, with a period of performance extending through June 2025. The contract does not have a set-aside designation, indicating it was open to full and open...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide Provocholine inhalation solution in 18 mL packages. The $4,426.65 delivery order has a completion date of March 7, 2024 and was awarded on March 6, 2024. Amerisourcebergen Drug Corp is a prime contractor for DLA Troop Support Medical, providing a wide range of pharmaceutical products and medical supplies to Department of...
- This federal contract award, valued at $1,650.39, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Provocholine inhalation solution, a medical product used in healthcare settings. The contract has an ultimate completion date of March 28, 2025 and is a Firm Fixed Price Delivery Order. It is not designated as a set-aside contract. AmerisourceBergen holds a...
- This award is a delivery order to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor, from the Defense Logistics Agency (DLA) Troop Support Medical. The $10,063.06 firm-fixed-price contract is for the supply of PROVOCHOLINE 100 MG VIALS, a medical product, with a completion date of September 25, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of...
- The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $2,670.65 order is for the provision of Provocholine Inhalation Solution, Pack 18ML, a pharmaceutical product. This delivery order falls under a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a...
- SPE2DB22D1202Indefinite Delivery Contract
- SPE2DB22D1202-SPE2DB25FVFC8Delivery Order
The Defense Logistics Agency awarded a $10,515.14 firm fixed price delivery order to AmerisourceBergen Drug Corp for the supply of Provocholine 100 mg vials. This non-set-aside contract was awarded on July 21, 2025, with an ultimate completion date of July 22, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. Provocholine is a pharmaceutical product used in respiratory function testing and is part of the broader range of medical commodities supplied through AmerisourceBergen's federal contract portfolio. This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with the Defense Logistics Agency's Troop Support Medical division, designated as SPE2DX, which is valued at $999,999,999 and extends through December 2026. This prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply pharmaceutical products and medical supplies to military healthcare programs and other government healthcare systems, including the Defense Health Agency and U.S. Coast Guard. The company's competitively awarded contract awards and demonstrated capability to fulfill federal medical supply requirements position it as a critical vendor for military and veteran healthcare pharmaceutical procurement.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $10.5k | 7/21/25 |